Determinants Along-Term Outcome in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastases

Jianmin Xu,Qi Lin,Dexiang Zhu
DOI: https://doi.org/10.1200/jco.2014.32.15_suppl.e14593
IF: 45.3
2014-01-01
Journal of Clinical Oncology
Abstract:e14593 Background: Simultaneous resection has been shown to be safe and effective in patients with synchronous colorectal liver metastasis (SCRLM), but which patients can get benefit from simultaneous resection remains unclear. Methods: We retrospective analyzed 154 prospectively collected SCRLM patients who underwent simultaneous resection between July 2003 and July 2013, the clinicopathologic data was analyzed with univariate and multivariate analysis. Results: Univariate analyses indicated that positive lymph nodes, vascular invasion, nerve invasion and BRAF mutation of colorectal cancer, number of liver metastases (LMs) (≥4), bilobar LM distribution, non-R0 resection of LMs and CEA level (>20 ng/ml) were significantly associated with poor overall survival (OS); tumor deposits, BRAF mutation, No. of LMs (≥4), bilobar distribution and extrahepatic metastasis resection were significantly associated with shorter disease-free survival (DFS). Multivariate analysis indicated, OS was significantly affected by positive lymph node status, vascular invasion, BRAF mutation, bilobar LM distribution and non-R0 resection of LMs. DFS was significantly affected by tumor deposits, BRAF mutation and bilobar LM distribution. We established clinical risk score (CRS) using these 5 predictors for OS and 3 predictors for DFS (each predictor equal to one point). Compared with a low CRS (0-2) and (0-1), a high score (≥3) and (≥2) was found to be highly predictive of short OS and DFS, respectively. Conclusions: Low CRS is an important determinant of long-term outcomes for the CRLM and suitable for simultaneous resection.
What problem does this paper attempt to address?